Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... or relapse/ refractory less than or equal to 10% blasts in bone marrow , or aplasia post-therapy. This includes ... in CR, or relapse with less than or equal 10% bone marrow blasts. CML with tyrosine kinase inhibitor failure in chronic or ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  2. Understanding Prognosis in MDS

    ... help determine prognosis—the percentage of bone marrow blasts (immature white blood cells), the number of cytopenias (low blood ... to help determine prognosis—the percentage of bone marrow blasts (immature white blood cells), the number of cytopenias (low blood ...

    Interview last updated 05/02/2012 - 4:36pm.

  3. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    ... or Mylotarg) MDS: Patients must have < 10% marrow blasts ; fewer than 10% marrow blasts must be documented by marrow examination within 3 weeks of initiation of ...

    Clinical Trial last updated 04/28/2016 - 2:45pm.

  4. MDS: Diagnosis

    ... bone marrow which are immature white blood cells called blasts . In people with AML, blasts make copies of themselves quickly. This slows the production of red ...

    Page last updated 01/20/2015 - 4:42pm.

  5. Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... recurrent disease (increased bone marrow blasts ) Refractory AML is defined as patients that have not achieved ... (< 5 white blood cell [WBC]/mm^3 and no blasts in cerebrospinal fluid [CSF]) will be eligible Research ...

    Clinical Trial last updated 07/14/2016 - 4:08pm.

  6. Intra-Osseous Co-Transplant of UCB and hMSC

    ... (CR2) or third complete remission (CR3) ≤ 10% blasts in the marrow and/or ≤ 5% blasts in the peripheral blood Acute lymphoblastic leukemia ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  7. The National Myelodysplastic Syndromes Natural History Study

    ... unexplained cytopenia , circulating peripheral blasts etc.) MDS or MDS/MPN overlap disorders and undergoing diagnostic ...

    Clinical Trial last updated 02/23/2017 - 1:36pm.

  8. MDS—The Past 40 Years. A Look at the Emerging Awareness and Classification of Myelodysplastic Syndromes.

    ... CMML) and refractory anemia with excess blasts (RAEB) that could be confused with acute leukemia. These conditions ... until the end of the century. Based on the percentage of blasts (young, immature blood cells) in bone marrow and blood, the FAB ...

    Page last updated 10/19/2015 - 2:29pm.

  9. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... or with myelodysplasia (MDS) with no circulating blasts and with less than 5% blasts in the bone marrow Planned myeloablative conditioning ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  10. Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

    ... in patients with refractory anemia with excess blasts , refractory anemia with excess blasts in transformation, or acute myeloid leukemia treated with this ...

    Clinical Trial last updated 04/28/2016 - 8:49am.